The Research and Development Team at HARMAN FINOCHEM LIMITED focuses on innovating and improving the company's pharmaceutical offerings, specifically in the areas of metformin and allopurinol. This entails conducting scientific research, developing new formulations, ensuring quality control, transferring technology, and managing analytical development. Their objective is to enhance product efficacy, safety, and quality while keeping up with regulatory standards and market demands.
View all